MS Companion
An AI-powered daily companion for people living with multiple sclerosis that turns medical research, fundraising milestones, and clinical-trial news into a personalized plain-language feed.
People living with MS and the family members who coordinate their care, fundraising, and research literacy
- Personalized research-feed translator that turns each new MS paper into a 3-sentence 'does this matter for me' summary
- Fundraiser tracker showing where each high-profile donation (like Mendoza's $500K gift) is actually going
- Symptom journal with pattern detection over time, exportable to share with a neurologist
- Care-team handoff notes that translate doctor visits into a plain-English recap for the family
Fernando Mendoza's $500,000 MS research gift just made national news — high-profile athlete donations always spike interest in the underlying disease, and MS patients and their families will be searching for context right now.
Real but niche: ~1M US MS patients and caregivers, and the Mendoza $500K gift is verified across People, 8newsnow, and University of Miami news, generating search interest — but demand is fragmented across many existing specialized apps.Fernando Mendoza Donates $500,000 for Multiple Sclerosis Research While Praising His Mom with Disease ↗Raiders' Fernando Mendoza, family present $500,000 gift for MS research ↗
Market is saturated with direct competitors: MultipleSclerosis.ai literally brands itself as an 'AI-Powered MS Companion,' BelongMS offers an AI mentor called 'Sophie,' plus icompanion.ms, MS Journey, MSCopilot, My MS Manager, Floodlight MS, and Aby — very little room for a new entrant.MultipleSclerosis.ai - AI-Powered MS Management ↗Multiple Sclerosis App - BelongMS with Sophie AI mentor ↗The best multiple sclerosis apps - Multiple Sclerosis News Today ↗
Free anchors dominate: MS Association of America (My MS Manager), Roche/Genentech (Floodlight MS), MSCopilot and Aby are all free; icompanion is the rare subscription model and still small. Caregivers in chronic-illness niches have low willingness to pay when credible orgs and pharma provide tools gratis.icompanion MS (free with subscription fees) ↗MS: Apps That Can Help You Manage Your Condition - WebMD ↗
MS is a chronic, lifelong disease so the underlying need is durable, but the 'Mendoza news spike' framing is short-lived — the research/clinical-trial feed is a feature layer, not a standalone moat, and incumbents will bolt it on.Mendoza Family's Gift Accelerates Breakthrough MS Research ↗
Technically straightforward (LLM over RSS/news feeds), but high regulatory/trust bar in healthcare, content-licensing costs for clinical-trial feeds, and difficulty achieving credibility against org-backed incumbents.Multiple Sclerosis Journey - Apps on Google Play ↗